Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111494) titled 'Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Medical College of Wisconsin
Condition:
Psoriatic Arthritis (PsA)
Intervention:
Drug: GLP-1 agonists
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 15, 2025
Target Sample Size: 22
Countries of Recruitment:
United States
To know more, visit https:...